Advances in Soft Tissue Sarcoma
Soft-tissue sarcomas (STSs) are a heterogeneous collection of rare tumors. As such, they can arise within any site of the body, including the extremities, trunk, retroperitoneum, and head and neck.
The goal of this activity is to provide oncology healthcare providers with knowledge that can be applied to developing a treatment plan for their patients with STS.
This activity is intended for oncology healthcare providers who care for patients with STS. No prerequisites required.
After participating in this activity, the participant will demonstrate the ability to:
- IDENTIFY clinical and pathological characteristics of STS and challenges of traditional treatment strategies.
- EVALUATE the efficacy and safety of first-line STS treatments, including recent changes to clinical practice guidelines.
- DESIGN a treatment plan for second-line STS therapy, incorporating newly approved agents utilized in various subtypes of STS.
Chair and Planner
David S. Ettinger, MD
Alex Grass Professor of Oncology
Sidney Kimmel Comprehensive Cancer Center
Nita Ahuja, MD
Professor of Surgery, Oncology, and Urology
Johns Hopkins University School of Medicine
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
- 1.00 ANCC